Idera Pharmaceuticals Inc $2.64

down -0.05


22/8/2014 04:00 PM  |  NASDAQ : IDRA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get IDRA Trend Analysis - it has outperformed the S&P 500 by 19%

Partner Headlines

  1. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth ...

    Benzinga
  2. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises ...

    Benzinga
  3. Earnings Scheduled For May 13, 2014

    Benzinga
  4. Idera Expands Management Team with Three Key Hires

    Benzinga
  5. Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as ...

    Benzinga
  6. Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares ...

    Benzinga
  7. Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks ...

    Benzinga
  8. Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After ...

    Benzinga
  9. Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 ...

    Benzinga
  10. Mid-Afternoon Market Update: 3D Printing Names Take a Hit From Barron's ...

    Benzinga
  11. Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares ...

    Benzinga
  12. Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales ...

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Morning Market Movers

    Benzinga
  15. Insiders Are Buying Idera Pharmaceuticals

    GuruFocus
  16. Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for ...

    Benzinga
  17. UPDATE: Piper Jaffray Initiates Idera Pharmaceuticals at Overweight on ...

    Benzinga
  18. Benzinga's Top Initiations

    Benzinga
  19. Benzinga's Small Cap Movers for Wednesday December 19, 2012

    Benzinga
  20. Idera Pharmaceuticals Announces Positive Results in Phase 2 Trial of IMO-31 ...

    Benzinga
  21. Health Care Sector Wrap

    FoxBusiness
  22. Idera Pharmaceuticals Presents Data in Preclinical Models of Lymphoma on ...

    Benzinga
Trading Center